For the Quarter Ending June 2025
Asia-Pacific (APAC)
• Dimethylformamide Price Index in APAC declined marginally by approximately 4% quarter-on-quarter, settling at USD 509/MT FOB Nanjing by late June. While upstream cost factors—including a modest rise in Dimethylamine prices—introduced some cost pressure, the overall market remained soft due to weakened demand from downstream sectors and persistent uncertainty across global trade channels.
• Why did the price of Dimethylformamide change in July 2025 in China? In early July 2025, Dimethylformamide prices remained stable as balanced supply-demand conditions persisted. Upstream feedstock prices held firm, and freight rates within the intra-Asia region increased by nearly 8%. However, downstream demand remained restrained, keeping prices flat despite rising logistics costs.
• The Dimethylformamide Production Cost Trend was moderately elevated in Q2 2025. While feedstock Dimethylamine showed upward momentum in early June, its impact on Dimethylformamide pricing was limited by sluggish market demand.
• Dimethylformamide Demand Outlook remained soft across Q2. Key consuming sectors—including textiles, synthetic leather, adhesives, and resins—exhibited subdued procurement patterns. Pharmaceutical demand stayed consistent, but overall industrial sentiment remained weak amid tariff uncertainty and competitive pricing.
• The export momentum of Dimethylformamide remained under pressure throughout the quarter. The Dimethylformamide export volumes were limited by weak demand from tariff-impacted industries like textiles and pharmaceuticals.
• Domestic procurement in China held steady but was cautious. While the pharmaceutical sector offered consistent offtake, industries reliant on Dimethylformamide as a solvent for coatings, resins, and leather applications showed little interest in long-term purchases.
North America (USA)
• Dimethylformamide Price Index in North America edged lower quarter-on-quarter. While feedstock Dimethylamine costs climbed modestly, demand from downstream sectors like coatings, adhesives, and polymers remained under pressure—offsetting any upward cost momentum.
• Why did the price of Dimethylformamide change in July 2025 in the USA? In early July, Dimethylformamide prices held steady. Though pharmaceutical demand stayed consistent, softness continued in industrial segments. Balanced supply—due to no significant plant outages—and stable logistics helped maintain price stability.
• The Dimethylformamide Production Cost Trend remained moderately stable in Q2 2025. U.S. Dimethylamine feedstock is introducing some cost pressure early in the quarter. However, energy and chemical input costs stabilized by June, and no major plant shutdowns occurred.
• Dimethylformamide Demand Outlook stayed mixed in Q2. The pharmaceutical sector provided a reliable offtake, supporting baseline volumes. However, industrial sectors such as coatings, polymers, and adhesives continued to see low procurement due to weak manufacturing activity and cautious inventory management.
• The export momentum of Dimethylformamide from North America was tepid. Despite competitive feedstock availability, limited global demand—particularly in Asia and Europe—and logistical frictions constrained export volumes.
• Domestic procurement in the USA remained selective. Buyers in pharma and specialty chemicals maintained steady, need-based purchasing. Conversely, industrial buyers postponed bookings amid weak contract flow, prioritizing inventory optimization over bulk acquisitions.
Europe
• The Dimethylformamide Price Index in Europe declined during the quarter-on-quarter period. Prices remained under pressure from abundant inventories and tepid demand across key sectors, though feedstock costs remained stable.
• Why did the price of Dimethylformamide change in July 2025 in Europe? In early July, Dimethylformamide prices remained mostly flat. Inventory levels stayed high, and demand from textiles, agrochemicals, and coatings remained subdued. Feedstock costs and logistics were stable, offering no strong impetus for price shifts.
• The Dimethylformamide Production Cost Trend stayed relatively stable during Q2 2025. Dimethylamine and formic acid costs showed minimal fluctuations. While energy and regulatory expenses remained imposed, producers managed inventories carefully without major production cuts.
• Dimethylformamide Demand Outlook continued to be soft through Q2. While pharmaceutical and specialty chemical applications provided some baseline consumption, key end-user sectors such as textiles, agrochemicals, coatings, and plastics remained cautious amid macroeconomic uncertainties, leading to conservative procurement behavior.
• The export momentum of Dimethylformamide from Europe remained muted. Elevated inventories and weak domestic offtake, paired with competitive import offers from Asia and the Middle East, limited outward shipments.
• Domestic procurement in Europe was restricted to short-term buying. Buyers favored just-in-time strategies, avoiding bulk contracts as demand remained unpredictable and confidence was low. Inventory drawdowns were slow, and purchasing was opportunistic rather than forward-looking.
For the Quarter Ending March 2025
North America
In Q1 2025, the North American Dimethylformamide (DMF) market exhibited a mixed price trend, shaped by sector-specific demand dynamics and external market pressures. The pharmaceutical sector continued to be a major demand driver, maintaining steady consumption due to the essential role of DMF in active pharmaceutical ingredient (API) synthesis and drug formulation. This consistent performance provided a strong base for market stability.
However, the chemical sector, particularly polymer and coating industries, saw weaker activity early in the quarter due to lingering winter-season slowdowns and inventory adjustments, leading to fluctuating procurement patterns. While feedstock costs remained relatively stable, occasional disruptions in logistics and supply chain operations caused regional inconsistencies in product availability and pricing. Sustainability trends and environmental compliance measures continued to influence operational strategies, encouraging investment in cleaner technologies and solvent recovery systems. Market participants adopted a cautious procurement approach, balancing between steady downstream needs and economic uncertainties.
Overall, while certain segments drove stable to firm demand, others contributed to subdued buying activity, leading to a mixed market performance. As industrial activity gradually picks up pace in the coming quarter, the outlook remains cautiously optimistic, hinging on broader economic stability and recovery in seasonal industrial demand.
APAC
In Q1 2025, the Dimethylformamide (DMF) market in the Asia-Pacific (APAC) region, particularly China, exhibited a stable to slightly bearish price trend, largely driven by moderate demand from downstream sectors and steady supply conditions. Throughout the quarter, DMF prices hovered within a narrow range, with FOB Nanjing assessments mostly between USD 537/MT and USD 540/MT. The overall sentiment remained subdued due to cautious procurement behaviour and the absence of significant demand surges from key end-use industries such as pharmaceuticals, textiles, and electronics.
During January, market activity slowed in anticipation of the Lunar New Year, and production scaled back accordingly. However, pre-holiday stockpiling and adequate inventory levels ensured that supply remained sufficient to meet moderate demand, leading to price stability. The pharmaceutical sector offered some support with robust and consistent consumption, while the textile sector saw mixed trends due to declining exports.
February witnessed brief price fluctuations influenced by localized supply-demand dynamics, but prices largely remained range-bound. Despite a slight recovery in industrial activity post-holiday, buyers maintained a rigid and essential purchasing approach.
By March, the market sustained its stable outlook. While feedstock dimethylamine prices rose modestly, they did not significantly impact DMF prices due to limited production adjustments. Overall, Q1 2025 showcased a mixed-to-stable pricing trend in the APAC DMF market, underpinned by cautious procurement and moderate downstream demand.
Europe
In Q1 2025, the European Dimethylformamide (DMF) market displayed a mixed price trend, shaped by uneven demand recovery and macroeconomic headwinds. The quarter began with subdued market sentiment, as downstream industries such as textiles and agrochemicals continued to exhibit weak procurement activity. Despite this, the pharmaceutical and specialty chemical sectors showed marginal improvement, particularly in regions witnessing increased R&D and formulation work, offering some price support.
Feedstock costs remained relatively stable, though minor fluctuations in Dimethylamine and formic acid prices added mild upward pressure during mid-quarter. Inventory levels remained balanced, with most producers adopting cautious production strategies to align with actual demand. However, inconsistent offtakes and price-sensitive buying behaviour led to occasional discounts and promotional pricing. The latter half of the quarter saw modest improvement, with seasonal demand recovery and export opportunities providing limited momentum. Nevertheless, the ongoing industrial slowdown and conservative buying patterns kept the overall market from gaining significant traction.
As a result, Q1 2025 reflected a mixed trend in the European DMF market, characterized by initial sluggishness and slight late-quarter improvements, with price movements largely dependent on sector-specific recovery and broader economic stabilization efforts.
For the Quarter Ending December 2024
North America
In the fourth quarter of 2024, the Dimethylformamide (DMF) market in North America experienced a notable increase in demand, driven primarily by the pharmaceutical and chemical industries. The region saw a moderate growth, reflecting the rising need for high-performance solvents in various industrial applications. This growth can be attributed to the moderate demand growth from pharmaceutical sector, where DMF is crucial for producing active pharmaceutical ingredients (APIs) and drug formulations due to its excellent solvency properties.
Additionally, the chemical industry's demand for DMF in polymer production and coating formulations contributed significantly to the market's performance. Environmental regulations and the shift towards sustainable production processes also played a role, as companies adopted cleaner technologies and better recycling methods to reduce their environmental impact.
Despite some challenges, such as fluctuations in raw material costs and geopolitical tensions, the DMF market in North America demonstrated resilience and innovation. The focus on sustainability and operational efficiency helped maintain steady growth, with companies investing in new technologies and enhancing their product portfolios. Overall, the DMF market in North America showed a positive trend in Q4 2024, with an increase in demand compared to the previous quarter, highlighting its importance in various industrial applications.
APAC
The Dimethylformamide (DMF) market in the Asia-Pacific (APAC) region particularly in China has experienced stable pricing, with only a 0.1% quarter-on-quarter price change. This stability can be attributed to several factors, including steady production costs and effective inventory management by manufacturers, particularly in China. The prices of key feedstocks, such as Dimethylamine, remained stable, ensuring consistent production costs, and contributing to the overall stability in DMF pricing. Demand from downstream sectors, such as the pharmaceutical and textile industries, showed growth potential, but overall demand remained moderate and subdued. The agrochemical sector faced challenges due to a weak pesticide market, which dampened overall procurement. Despite these weak demand conditions, the supply side remained balanced, with manufacturers maintaining high inventory levels and taking a cautious approach to pricing and orders. As a result, the market experienced little fluctuation, and producers offered discounts to encourage orders without overstocking. With smooth shipping and no major supply disruptions, production remained consistent. The combination of stable production costs, cautious downstream demand, and effective inventory management led to a steady market environment. While the overall sentiment was bearish, the equilibrium between supply and demand prevented significant price changes, contributing to the overall stability of DMF prices in the region.
Europe
In Q4 2024, the Dimethylformamide (DMF) market in Europe experienced a relatively stable pricing trend, with limited fluctuations observed during the period. Prices remained supported by steady production costs and moderate demand from key downstream sectors. The overall market sentiment was cautious, as economic uncertainties and slow demand from industries such as textiles and agriculture influenced procurement levels. The pharmaceutical sector showed slight growth in the latter half of the quarter, driven by ongoing innovation and research activities, but this did not significantly boost overall DMF consumption. Feedstock prices, particularly for Dimethylamine, remained stable throughout the quarter, contributing to controlled production costs and helping maintain price stability in the DMF market. Inventory levels were generally adequate, preventing any significant supply shortages or price volatility. However, the slow recovery in the broader European economy and the cautious outlook in manufacturing and industrial sectors limited the demand for DMF. Manufacturers in the region adopted a conservative approach, focusing on meeting contract-based orders and offering discounts to stimulate demand. While there were no major supply disruptions, weak purchasing sentiment from downstream industries, particularly in the agrochemical sector, kept the market sentiment subdued. Overall, the Q4 2024 DMF market in Europe remained stable, with the balance between supply and demand preventing any sharp price changes despite moderate demand and cautious market conditions.
For the Quarter Ending September 2024
North America
In Q3 2024, the Dimethylformamide (DMF) market in North America experienced several key trends. Prices saw a slight increase due to higher freight costs and favourable conditions in the feedstock market. The cost-effective production helped maintain stable prices despite international market tensions. The demand for DMF remained strong, driven by its use as a solvent in the chemical processing, pharmaceutical, and textile industries.
The growing demand for synthetic leather in the footwear and automotive industries also contributed to the market's growth. The supply chain faced challenges, including higher freight costs and logistical issues. However, the production remained steady, supported by cost-effective feedstock availability.
There was an increased focus on health and safety regulations due to DMF's potential health risks, such as skin irritation and liver damage. Companies are investing in safer handling practices and exploring less harmful substitutes. The market is expected to continue growing, supported by the demand from various end-use industries. However, stringent regulations and health concerns may pose challenges to the market's expansion.
APAC
Dimethylformamide pricing in the APAC Region during Q3 2024 has witnessed a significant decrease, reflecting a challenging market environment. Various factors have influenced this downturn, including weakened demand from downstream sectors like agriculture and pharmaceuticals, leading to an oversupply situation. Additionally, the ongoing global economic uncertainties have contributed to the downward pressure on prices. In China specifically, the market has experienced the most pronounced price changes, with a notable -27% decrease compared to the same quarter last year. The quarter-on-quarter decline of -10% further highlights the negative trend in pricing. The second half of the quarter saw a continued drop in prices, with a -4% decrease compared to the first half. The latest quarter-ending price of USD 540/MT of Dimethylformamide FOB-Nanjing in China underscores the persisting downward sentiment in the market. Overall, the pricing environment for Dimethylformamide in the APAC Region has been consistently negative, with prices reflecting a challenging and unstable market landscape.
Europe
In Q3 2024, the Dimethylformamide (DMF) market in Europe experienced several key trends. Prices saw a slight increase due to higher freight costs and favorable conditions in the feedstock market. The costeffective production helped maintain stable prices despite international market tension. The demand for DMF remained strong, driven by its use as a solvent in the chemical processing, pharmaceutical, and textile industries. The growing demand for synthetic leather in the footwear and automotive industries also contributed to the market's growth.The supply chain faced challenges, including higher freight costs and logistical issues. However, the production remained steady, supported by costeffective feedstock availability.There was an increased focus on health and safety regulations due to DMF's potential health risks, such as skin irritation and liver damage. Companies are investing in safer handling practices and exploring less harmful substitutes.The market is expected to continue growing, supported by the demand from various enduse industries. However, stringent regulations and health concerns may pose challenges to the market's expansion.
Frequently Asked Questions (FAQs):
1. What is the current price of Dimethylformamide in APAC?
By the end of Q2 2025, Dimethylformamide prices in China stood at approximately USD 509/MT FOB Nanjing.
2. Why did Dimethylformamide prices change in July 2025?
• APAC: Prices remained stable as balanced supply-demand conditions continued. While freight rates rose and feedstock costs held firm, muted downstream demand prevented any significant movement.
• North America: Prices held steady amid consistent pharmaceutical demand and subdued industrial activity. No major disruptions in production or logistics helped keep prices unchanged.
• Europe: Prices remained mostly flat as high inventory levels and weak demand from textiles, agrochemicals, and coatings offset any cost-side pressures. Feedstock and logistics remained neutral contributors.
